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Short-Term Culture With the Caspase Inhibitor z-VAD.fmk Reduces
Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic
Outcome of the Graft
Marta Montolio, Noèlia Téllez, Montserrat Biarnés, Joan Soler, and Eduard Montanya
Laboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge,
University of Barcelona, Barcelona, Spain
In the initial days after transplantation islets are particularly vulnerable and show increased apoptosis and
necrosis. We have studied the effects of caspase inhibition on this early beta cell death in syngeneically
transplanted islets. Streptozotocin-diabetic C57BL/6 mice were transplanted with 150 syngeneic islets, an
insufficient mass to restore normoglycemia, preincubated with or without the pan-caspase inhibitor z-VAD.
fmk 2 h before transplantation. Beta cell apoptosis was increased in control islets on day 3 after transplanta-
tion (0.28 ± 0.02%) compared with freshly isolated islets (0.08 ± 0.02%, p < 0.001), and was partially re-
duced in transplanted islets preincubated with z-VAD.fmk 200 µM (0.14 ± 0.02%, p = 0.003) or with z-
VAD.fmk 500 µM (0.17 ± 0.01%, p = 0.012), but not with a lower z-VAD.fmk (100 µM) concentration.
Diabetic mice transplanted with islets preincubated with z-VAD.fmk 500 µM showed an improved metabolic
evolution compared with control and z-VAD.fmk 200 µM groups. The z-VAD.fmk 500 µM group showed
an overall lower blood glucose after transplantation (p = 0.02), and at the end of the study blood glucose
values were reduced compared with transplantation day (15.7 ± 3.6 vs. 32.5 ± 0.5 mmol/L, p = 0.001). In
contrast, blood glucose was not significantly changed in control and z-VAD.fmk 200 µM groups. Four
weeks after transplantation beta cell mass was higher in z-VAD.fmk 500 µM group (0.15 ± 0.02 mg) than
in the control group (0.10 ± 0.02 mg) (p = 0.043). In summary, the treatment of freshly isolated islets with
the caspase inhibitor z-VAD.fmk reduced the subsequent apoptosis of the islets once they were transplanted
and improved the outcome of the graft.
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INTRODUCTION Thus, it may be expected that a reduction in the initial
beta cell death would improve the outcome of the graft.
However, this has not been directly determined. More-Transplanted islets are particularly vulnerable in the
initial days after transplantation (5), and we recently re- over, because initial apoptosis after transplantation is
low in absolute terms it is not known whether a reducedported that, even in syngeneic grafts, more than 60% of
transplanted islet mass was lost due to increased apopto- apoptosis would modify the evolution of the graft.
Caspases are the central executioners of the apoptoticsis and necrosis (2). Several factors may play a role in
the initial death of islets, including damage during isola- process (8) and accordingly caspase activation has been
found in beta cells undergoing apoptosis (33). These en-tion (23,29), technical problems in the transplantation
procedure (12), islet hypoxia (6), absence of survival zymes participate in a cascade triggered in response to
apoptotic signals that end in cleavage of proteins, lead-factors present in the nonendocrine pancreas (10), dis-
ruption of islets cellular connections to extracellular ma- ing to disassembly of the cell (28). Caspase inhibitors
(19,30) have been shown to reduce apoptotic cell deathtrix (27), or nonspecific inflammation at the grafted site
(21). This early islet death can contribute to increase both in vitro (11,25) and in vivo (3,4,9). Notably, cas-
pase inhibition reduced apoptosis in nigral transplantsthe beta cell mass required to achieve normoglycemia in
diabetic recipients and can have a negative effect on the and increased the number of surviving dopaminergic
cells (24). In human islets the pan-caspase inhibitor, z-long-term evolution of the graft after transplantation.
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Val-Ala-DL-Asp-fluoromethylketone (z-VAD.fmk), re- and were transplanted into STZ-diabetic recipients. One
hundred and fifty islets is an insufficient beta cell massduced beta cell death in human beta cells in vitro (1,22).
However, the in vivo effect of caspase inhibition on islet to restore normoglycemia in this model and therefore
animals were expected to remain hyperglycemic (16).cell death has not been determined. The aim of this
study was to determine whether exposure of isolated is- Grafts were harvested 4 weeks after transplantation and
beta cell mass was evaluated. Blood glucose and bodylets to the pan-caspase inhibitor z-VAD.fmk before
transplantation could reduce or prevent the initial apo- weight were determined on days 3 and 7 after transplan-
tation, and weekly thereafter. Animals were consideredptotic beta cell death after transplantation and whether
this reduction could improve the outcome of the graft. normoglycemic when blood glucose values after trans-
plantation were <8.9 mmol/L (mean + 2 SD of all ani-
MATERIALS AND METHODS mals included in the study before streptozotocin injec-
Animals tion).
Male inbred C57Bl/6 mice (Harlan France SARL,
Islet Isolation, Transplantation, and Graft HarvestingGannat, France) aged 8–12 weeks, were used as donors
Islets were isolated by collagenase (Collagenase P,and recipients of transplantation. The recipients were
Boehringer Mannheim Biochemicals, Mannheim, Ger-made diabetic by a single IP injection of streptozotocin
many) digestion of the pancreas as previously described(STZ) (Sigma, St. Louis, MO) 180 mg/kg body weight,
(18). Isolated islets were hand-picked under stereomi-freshly dissolved in citrate buffer (pH 4.5). Transplanta-
croscope two or three times, until a population of puretion was performed 7–14 days after STZ injection. Be-
islets was obtained. To homogenize the islet populationfore transplantation, diabetes was confirmed by the pres-
among groups, and to reduce the effect of hypoxia onence of hyperglycemia, weight loss, and polyuria. Only
transplanted islets, only those islets >75 and <250 µmthose mice with a blood glucose higher that 20 mmol/L
in diameter were used for transplantation.on a minimum of two consecutive measurements were
After isolation, islets were counted into groups of 150transplanted. Blood glucose was determined between
islets and cultured at 37°C and 5% CO2 for 2 h in RPMI-0900 and 1100 h in nonfasting conditions. Blood was
1640 medium supplemented with 11.1 mM glucose andobtained from the snipped tail and glucose was mea-
10% fetal calf serum (FCS, Biological Industries, Beitsured with a portable glucose meter (Glucocard Mem-
Haemek, Israel) and with z-VAD.fmk 100, 200, or 500ory, A. Menarini Diagnostics, Barcelona, Spain). Animals
µM or with DMSO 0.05% with no z-VAD.fmk (controlwere kept under conventional conditions in climatized
group). Immediately after the 2-h culture, islets wererooms with free access to tap water and standard pel-
transplanted under the left kidney capsule of mice recip-leted food.
ients. After transplantation, the capsulotomy was cauter-
Experimental Protocol ized with a disposable low-temperature cautery pen (AB
Medica, S.A., Barcelona), and the lumbar incision wasThe ability of different concentrations of the nonse-
lective inhibitor of caspase activation, z-VAD.fmk sutured (18).
Grafts were harvested under the microscope as pre-(Bachem, Bubendorf, Switzerland), to reduce apoptosis
in transplanted beta cells was initially tested on day 3 viously described (2), and after the retrieval of the graft
the kidney cortex was carefully examined to ensure thatafter transplantation. Islets were preincubated for 2 h
with z-VAD.fmk 100 µM (n = 3), 200 µM (n = 6), 500 no islet tissue was left in place. The graft was immedi-
ately immersed in 4% paraformaldehyde fixative andµM (n = 6), or with no z-VAD.fmk (control group, n =
9), and were transplanted under the kidney capsule of processed for paraffin embedding.
the recipient. z-VAD.fmk was prepared in dimethyl sul-
Apoptosis Detectionphoxide (DMSO, Sigma). In all experimental conditions,
including the control group, the final concentration of Graft sections (2 µm) were double-stained by im-
munoperoxidase for apoptotic nuclei using the deoxy-DMSO in the culture media was kept at 0.05%. Three
days after transplantation, the grafts were harvested and nucleotidyl transferase-mediated dUTP nick-end label-
ing (TUNEL) technique (In Situ Cell Death Detectionbeta cell apoptosis was determined.
The z-VAD.fmk concentrations that were found to Kit, ApopTag, Intergene, Oxford, UK), and by alkaline
phosphatase for the endocrine non-beta cells of the is-induce a reduction in transplanted beta cell apoptosis
were then subsequently used to analyze the effects on lets, as described (2). We stained the endocrine non-beta
cells instead of beta cells because the severe hyperglyce-metabolic evolution. One hundred and fifty freshly iso-
lated islets were preincubated for 2 h before transplanta- mia that was expected is associated with beta cell de-
granulation, resulting in negative or weak staining. Aftertion with z-VAD.fmk 200 µM (n = 10), z-VAD.fmk 500
µM (n = 7), or DMSO 0.05% (control group, n = 15) immunoperoxidase staining, beta cells and apoptotic nu-
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clei were counted using an Olympus BH-2 microscope volume, determined with image-analytical software
(AnalySIS 3.0; Soft Imaging System, Münster, Ger-connected to a video camera with a color monitor. When
assessing apoptotic nuclei we excluded regions with ne- many) on sections of the islet pellets.
crosis. Beta cell apoptosis was expressed as percentage
Statistical Analysisof TUNEL-positive beta cells. A minimum of 1000 cell
Results were expressed as mean ± SEM. Differencesnuclei were counted per graft; the sections were system-
between means were evaluated using the one-way analy-atically sampled, all endocrine nuclei were counted, and
sis of variance (ANOVA) or the Kruskal-Wallis test asa second section was included when needed.
appropriate. The Fisher’s PLSD (protected least signifi-Apoptosis in islets before transplantation was deter-
cant difference) method or the Mann-Whitney test weremined in seven groups of 150 islets isolated on different
used to determine specific differences between meansdays. After isolation, the islets were washed in phos-
when determined as significant by ANOVA main effectsphate-buffered saline (PBS) and pelleted in 4% para-
analysis or by Kruskal-Wallis test, respectively. The sta-formaldehyde fixative. Sections of the islet pellet were
tistical software SPSS 10.0 was used. A value of p < 0.05double-stained for TUNEL and for endocrine non-beta
was considered significant.cells, and beta cell apoptosis was expressed as percent-
age of TUNEL-positive beta cells. In addition, beta cell
RESULTSapoptosis in normal pancreas was determined in eight
Dose of z-VAD.fmk That Effectively Reduces Apoptosispancreas from control C57BL/6 mice. A midlaparotomy
in Transplanted Isletswas performed, and the pancreas was exposed, the ani-
mal was killed, and the pancreas was immediately ex- To identify which dose of the caspase inhibitor was
cised and fixed in 4% paraformaldehyde. To determine capable to reduce apoptosis in transplanted islets, we
beta cell apoptosis, sections of the pancreas were dou- transplanted 150 syngeneic islets previously cultured with
ble-stained and counted as described for grafts and iso- 100, 200, and 500 µM z-VAD.fmk. Grafts were harvested
lated islets. 3 days later and beta cell apoptosis was analyzed.
On day 3 after transplantation, beta cell apoptosis was
Islet Cell Necrosis significantly increased in the control group (0.28 ± 0.02%)
The area of necrosis was measured by point counting compared with freshly isolated islets (0.08 ± 0.02%, p <
morphometry (32) on the same graft sections used to 0.001) and with normal pancreas (0.05 ± 0.02%, p < 0.001)
quantify beta cell mass. The necrotic area was expressed (Fig. 1). Beta cell apoptosis in grafts of islets preincu-
as percentage of intercepts over necrotic tissue divided bated with z-VAD.fmk 100 µM was not modified (0.34 ±
by intercepts over islet tissue (beta and non-beta cells) 0.08%). However, preincubation with z-VAD.fmk 200
and necrotic area (2). and 500 µM before transplantation reduced subsequent
beta cell apoptosis in graft islets by 50% (0.14 ± 0.02%,
Beta Cell Mass p = 0.003) and 40% (0.17 ± 0.01%, p = 0.012), respec-
Methods used for measurement of beta cell mass tively. On the other hand, the large necrotic areas found
have been described in detail (16,18). Beta cell mass of on day 3 after transplantation were unaffected by cas-
islet grafts was measured by point counting morphome- pase inhibition (control group: 23.6 ± 9.6%; z-VAD.fmk
try on 3-µm sections using a 48-point grid to obtain the 200 µM group: 27.8 ± 10.7%; z-VAD.fmk 500 µM group:
number of intercepts over beta cells, over endocrine 17.5 ± 6.1%), suggesting that reduced apoptosis did not
non-beta cells, and over other tissue. The beta cell rela- result in increased necrotic cell death. On day 30, no
tive volume was calculated by dividing the intercepts necrosis was found in any graft.
over beta cells by intercepts over total tissue; then beta
Effect of z-VAD.fmk on Islet Graft Evolutioncell mass was estimated by multiplying beta cell relative
volume by graft weight. Metabolic Evolution of Transplanted Animals. To
determine whether reduction in beta cell apoptosis couldThe beta cell mass of islets at the time of transplanta-
tion was determined in 10 groups of 150 isolated islets, improve graft survival we transplanted a marginal beta
cell mass (150 islets) into diabetic syngeneic recipientsand the beta cell mass after 3-day culture in RPMI-1640
medium supplemented with 11.1 mM glucose and 10% and monitored the metabolic evolution for 4 weeks. Be-
fore transplantation islets were preincubated with z-VAD.FCS was determined in nine groups of 150 islets. The
islets were washed in PBS and pelleted in 4% parafor- fmk 200 or 500 µM, the concentrations that we had
found to reduce beta cell apoptosis on day 3 after trans-maldehyde fixative; any excess of paraformaldehyde
was removed by capillary action, and the pellet was plantation.
Blood glucose and body weight were similar in allweighed. Beta cell mass was obtained by multiplying
the weight of the islets by the percentage of beta cell groups when injected with STZ as well as when trans-
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Figure 1. Beta cell apoptosis in pancreas (n = 8), freshly isolated islets (n = 7), and islet grafts
on day 3 after transplantation. Islets in transplanted groups (Tx) were preincubated for 2 h in
the absence of z-VAD.fmk (n = 9) or with z-VAD.fmk 100 µM (n = 3), 200 µM (n = 6), and
500 µM (n = 6). Apoptosis was expressed as percentage of apoptotic nuclei over beta cells.
Values are means ± SEM. Kruskal-Wallis, p < 0.001; Mann-Whitney: *p < 0.05 pancreas versus
all other groups but islets. **p < 0.02 islets versus all other groups but pancreas and Tx 200
µM z-VAD.fmk. †p < 0.02 Tx versus Tx 200 and 500 µM z-VAD.fmk.
planted (Table 1). Because 150 islets is an insufficient mmol/L) compared with transplantation day (32.5 ± 0.5
mmol/L, p = 0.001), but were not significantly differentmass to restore normoglycemia (16), most of the animals
(73.4%) transplanted with control islets remained hyper- in the control (22.8 ± 3.0 vs. 31.0 ± 0.9 mmol/L) and z-
VAD.fmk 200 µM (22.6 ± 3.9 vs. 32.9 ± 0.2 mmol/L)glycemic 4 weeks after transplantation. In the two groups
transplanted with islets preincubated with 200 or 500 groups. Body weight after transplantation showed a sim-
ilar evolution as blood glucose, but differences did notµM z-VAD.fmk, 70% and 57% of the recipients re-
mained hyperglycemic 4 weeks after transplantation, re- reach statistical significance (Fig. 2B).
spectively. When blood glucose evolution after trans-
plantation (from day 3 to day 28) was considered, blood Beta Cell Mass in Transplanted Islets. Beta cell
mass in transplanted islets preincubated with 200 or 500glucose was different among the three groups (Kruskal-
Wallis, p = 0.02), with lower values in the z-VAD.fmk µM z-VAD.fmk, or with DMSO 0.05% was determined
on days 3 and 28 after transplantation. The initially500 µM group (21.2 ± 1.5 mmol/L) than in the control
(25.3 ± 1.1 mmol/L, p = 0.008) and z-VAD.fmk 200 µM transplanted beta cell mass, measured in 150 freshly iso-
lated islets (0.29 ± 0.02 mg), was reduced in all three(25.2 ± 1.2 mmol/L, p = 0.032) groups (Fig. 2A). Four
weeks after transplantation, blood glucose values were groups on day 3 after transplantation: control group
(0.10 ± 0.02 mg), z-VAD.fmk 200 µM (0.07 ± 0.01 mg),reduced in the z-VAD.fmk 500 µM group (15.7 ± 3.6
Table 1. Characteristics of Experimental Groups
Graft Removal
(4 Weeks After
Streptozotozin Injection Transplantation Transplantation)
Blood Glucose Body Blood Glucose Body Blood Glucose Body
Group n (mmol/L) Weight (g) (mmol/L) Weight (g) (mmol/L) Weight (g)
Control (DMSO 0.05%) 15 6.9 ± 0.2 25.0 ± 0.2 31.0 ± 0.9 23.3 ± 0.4 22.8 ± 3.0 24.5 ± 0.6
z-VAD.fmk 200 µM 10 6.8 ± 0.5 24.8 ± 0.3 33.0 ± 0.2 23.0 ± 0.6 22.6 ± 3.9 25.0 ± 0.5
z-VAD.fmk 500 µM 7 7.1 ± 0.4 24.7 ± 0.2 32.5 ± 0.5 23.4 ± 0.4 15.7 ± 3.6 25.7 ± 0.5
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early graft failure. This early beta cell loss increases the
islet number required for successful islet transplantation,
and it can also limit the long-term survival of the graft,
which has been shown to be dependent on the initially
transplanted beta cell mass (13,14,31). The understand-
ing of the events that take place in the crucial initial
days after transplantation is limited, but we have shown
the contribution of both necrosis and apoptosis to early
beta cell death in transplanted islets (2). On day 3 after
transplantation, extensive areas of necrosis (about 30%
of the transplanted islet mass) were identified in the
graft, and beta cell apoptosis was 10-fold higher than in
normal pancreatic beta cells. However, the number of
apoptotic beta cells was still quite low, 0.3–0.4% of the
whole beta cell population in the graft, and the signifi-
cance of this increased beta cell apoptosis to the graft
outcome could be questioned. We have hypothesized
that because apoptosis is a very rapid process, the detec-
tion of this higher frequency of apoptotic beta cells re-
flected in fact an important increment in total beta cell
apoptosis, sufficient to significantly reduce beta cell
mass (2). The finding, in the current study, that even a
partial reduction in early apoptosis was able to improve
the outcome of the graft confirms the biological signifi-
cance of the increased beta cell apoptosis in early islet
transplantation.
The effects of z-VAD.fmk on beta cell apoptosis in
transplanted islets were dose dependent. The 100 µM
concentration, which was sufficient to reduce cytokine-
induced beta cell apoptosis in mouse islets in vitro (17),
did not reduce beta cell apoptosis when islets were sub-
sequently transplanted. A higher concentration (200
Figure 2. Evolution of blood glucose (A) and body weight
(B) in control group (■), z-VAD.fmk 200 µM group (), and
z-VAD.fmk 500 µM group (). STZ: day of streptozotocin
injection. Tx: day of islet transplantation.
and z-VAD.fmk 500 µM (0.09 ± 0.01 mg) (p < 0.001)
(Fig. 3). In contrast, 3 days of culture did not modify
the beta cell mass of 150 islets (0.27 ± 0.04 mg), indicat-
ing that the beta cell mass reduction found in day 3
grafts was due to transplantation, not to the fact that
islets were 3 days old. Although the grafted beta cell
mass was still reduced in all three transplanted groups 4
weeks after transplantation, it had increased in animals
transplanted with islets preincubated with 500 µM z-
VAD.fmk, and was higher than in the control group Figure 3. Beta cell mass in 150 isolated islets, and islet grafts
on days 3 and 28 after transplantation Black bars: control is-(control: 0.10 ± 0.02 mg; z-VAD.fmk 500 µM: 0.15 ±
lets; white bars: islets preincubated (2 h) with z-VAD.fmk 2000.02 mg, p = 0.043).
µM before transplantation; gray bars: islets preincubated (2 h)
with z-VAD.fmk 500 µM before transplantation. Values areDISCUSSION
means ± SEM. ANOVA, p < 0.001; Fisher PLSD: *p < 0.001
The massive beta cell death that takes place in the 150 freshly isolated islets versus all other groups. †p < 0.05
control versus z-VAD.fmk 500 µM on day 28.initial days after transplantation plays a major role in
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µM) achieved a significant reduction in transplanted information about the effectiveness of the intervention
that can be obtained if graft parameters such as beta cellbeta cell apoptosis but was, however, insufficient to
modify the metabolic evolution of the recipient. Eventu- mass, replication, or death are measured. For instance,
we have shown that maintaining normoglycemia in theally, the incubation of islets with a 500 µM zVAD.fmk
resulted in both the reduction in transplanted beta cell initial days after transplantation improves the outcome
of the graft and reduces the beta cell mass required toapoptosis and the improvement in the metabolic out-
come after transplantation. A similar dose dependency achieve normoglycemia (15). However, the quantifica-
tion of grafted beta cell mass unexpectedly disclosedin caspase inhibition of apoptosis has been shown in se-
rum deprivation-induced neuronal death (24). Moreover, that normoglycemia did not preserve the transplanted
beta cell mass in the early days after transplantation, andhigh concentrations of the caspase inhibitor Ac-YVAD.
cmk (500 µM) were successfully used in nigral trans- that the beneficial effect was probably due to the preser-
vation of beta cell function in transplanted islets main-plants (24). The requirement of high concentrations of
caspase inhibitor in order to achieve an effective inhibi- tained in normoglycemic conditions (15,20). In the cur-
rent experiments, the measurement of beta cell apoptosistion of islet apoptosis in transplanted islets, particularly
compared with the lower concentrations that have been in islet grafts revealed the inhibitory effects of z-VAD.
fmk 200 µM, a beneficial effect that would have beenuseful in vitro, may reflect the multiplicity and intensity
of the stimulus contributing to beta cell death in the missed if only the metabolic evolution had been deter-
mined. This beneficial effect was then confirmed by theearly days after transplantation.
Despite the significant reduction in beta cell apopto- improved metabolic evolution found when z-VAD.fmk
500 µM was used, but also, and importantly, by thesis and the improved metabolic outcome, beta cell mass
was still significantly reduced initially after transplanta- higher beta cell mass in the graft.
In summary, we have found that the incubation oftion, and 57% of the recipients transplanted with islets
preincubated with z-VAD.fmk 500 µM remained hyper- freshly isolated islets with an appropriate dose of the
caspase inhibitor z-VAD.fmk reduced beta cell apopto-glycemic. Even though beta cell apoptosis was reduced
by 50% in islets cultured with z-VAD.fmk before trans- sis when islets were subsequently transplanted. This re-
duction improved the metabolic evolution of the graftplantation, apoptosis was still considerably higher than
in normal pancreas, and sufficient to result in significant and partially preserved the transplanted beta cell mass,
indicating the biological significance of initial beta cellbeta cell death. In addition, it has been shown that inhi-
bition of caspase activation cannot rescue those cells death, and in particular of beta cell apoptosis, on the
long-term outcome of the graft. Our results confirm thatthat have been irreparably damaged and that may end
up dying, even though more slowly and without the there is a window for therapeutic intervention on iso-
lated islets, before they are transplanted, that can be usedmorphological and biochemical markers of apoptosis
(7). Death from nonapoptotic programmed cell death has to modify the characteristics of the islets and to improve
the outcome of the graft.been described after the use of pharmacological modula-
tors of apoptotic pathway in neurodegenerative pro-
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